Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager

Novo Nordisk A/S

CSE:NOVO B

Watchlist

DCF Valuation

Price: 907.4 DKK -0.75% Market Closed

Updated: Aug 14, 2024

Have any thoughts about
Novo Nordisk A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 907.4 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

NOVO B Alert

Novo Nordisk A/S

907.4

-6.9 (-0.75%)

52 Week Range	616.3852 1 028
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Novo Nordisk A/S

What unique competitive advantages
does Novo Nordisk A/S hold over its rivals?

What risks and challenges
does Novo Nordisk A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Novo Nordisk A/S.

What unique competitive advantages
does Novo Nordisk A/S hold over its rivals?

What risks and challenges
does Novo Nordisk A/S face in the near future?

Summarize the latest earnings call
of Novo Nordisk A/S.

What significant events have occurred
in Novo Nordisk A/S over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Novo Nordisk A/S.

Provide P/S
for Novo Nordisk A/S.

Provide P/E
for Novo Nordisk A/S.

Provide P/OCF
for Novo Nordisk A/S.

Provide P/FCFE
for Novo Nordisk A/S.

Provide P/B
for Novo Nordisk A/S.

Provide EV/S
for Novo Nordisk A/S.

Provide EV/GP
for Novo Nordisk A/S.

Provide EV/EBITDA
for Novo Nordisk A/S.

Provide EV/EBIT
for Novo Nordisk A/S.

Provide EV/OCF
for Novo Nordisk A/S.

Provide EV/FCFF
for Novo Nordisk A/S.

Provide EV/IC
for Novo Nordisk A/S.

Show me price targets
for Novo Nordisk A/S made by professional analysts.

What are the Revenue projections
for Novo Nordisk A/S?

How accurate were the past Revenue estimates
for Novo Nordisk A/S?

What are the Net Income projections
for Novo Nordisk A/S?

How accurate were the past Net Income estimates
for Novo Nordisk A/S?

What are the EPS projections
for Novo Nordisk A/S?

How accurate were the past EPS estimates
for Novo Nordisk A/S?

What are the EBIT projections
for Novo Nordisk A/S?

How accurate were the past EBIT estimates
for Novo Nordisk A/S?

Compare the revenue forecasts
for Novo Nordisk A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Novo Nordisk A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Novo Nordisk A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Novo Nordisk A/S compared to its peers.

Compare the P/E ratios
of Novo Nordisk A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Novo Nordisk A/S with its peers.

Analyze the financial leverage
of Novo Nordisk A/S compared to its main competitors.

Show all profitability ratios
for Novo Nordisk A/S.

Provide ROE
for Novo Nordisk A/S.

Provide ROA
for Novo Nordisk A/S.

Provide ROIC
for Novo Nordisk A/S.

Provide ROCE
for Novo Nordisk A/S.

Provide Gross Margin
for Novo Nordisk A/S.

Provide Operating Margin
for Novo Nordisk A/S.

Provide Net Margin
for Novo Nordisk A/S.

Provide FCF Margin
for Novo Nordisk A/S.

Show all solvency ratios
for Novo Nordisk A/S.

Provide D/E Ratio
for Novo Nordisk A/S.

Provide D/A Ratio
for Novo Nordisk A/S.

Provide Interest Coverage Ratio
for Novo Nordisk A/S.

Provide Altman Z-Score Ratio
for Novo Nordisk A/S.

Provide Quick Ratio
for Novo Nordisk A/S.

Provide Current Ratio
for Novo Nordisk A/S.

Provide Cash Ratio
for Novo Nordisk A/S.

What is the historical Revenue growth
over the last 5 years for Novo Nordisk A/S?

What is the historical Net Income growth
over the last 5 years for Novo Nordisk A/S?

What is the current Free Cash Flow
of Novo Nordisk A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Novo Nordisk A/S.

NOVO B

Cash Flow Statement

Cash from Financing Activities

Novo Nordisk A/S
Cash from Financing Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Novo Nordisk A/S
Cash from Financing Activities Peer Comparison

Comparables:

HLUN A

ALK B

STENO

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company		Cash from Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Novo Nordisk A/S CSE:NOVO B	Cash from Financing Activities -kr68.9B	CAGR 3-Years -28%	CAGR 5-Years -15%	CAGR 10-Years -10%
	H Lundbeck A/S CSE:HLUN A	Cash from Financing Activities -kr2.1B	CAGR 3-Years 5%	CAGR 5-Years N/A	CAGR 10-Years N/A
	ALK-Abello A/S CSE:ALK B	Cash from Financing Activities -kr31m	CAGR 3-Years 21%	CAGR 5-Years -2%	CAGR 10-Years N/A
S	Stenocare A/S CSE:STENO	Cash from Financing Activities kr15.3m	CAGR 3-Years -25%	CAGR 5-Years -8%	CAGR 10-Years N/A

What is Novo Nordisk A/S's Cash from Financing Activities?

Cash from Financing Activities
-68.9B DKK

Based on the financial report for Mar 31, 2024, Novo Nordisk A/S's Cash from Financing Activities amounts to -68.9B DKK.

What is Novo Nordisk A/S's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 10Y
-10%

Over the last year, the Cash from Financing Activities growth was -29%. The average annual Cash from Financing Activities growth rates for Novo Nordisk A/S have been -28% over the past three years , -15% over the past five years , and -10% over the past ten years .

Novo Nordisk A/S
CSE:NOVO B

Novo Nordisk A/S
Cash from Financing Activities

Novo Nordisk A/S
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

See Also

What is Novo Nordisk A/S's Cash from Financing Activities?

Cash from Financing Activities
-68.9B DKK

What is Novo Nordisk A/S's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 10Y
-10%

Company

Help

Tools

Stocks

Novo Nordisk A/S CSE:NOVO B

Novo Nordisk A/S Cash from Financing Activities

Novo Nordisk A/S Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis Latest Figures & CAGR of Competitors

See Also

What is Novo Nordisk A/S's Cash from Financing Activities? Cash from Financing Activities -68.9B DKK

What is Novo Nordisk A/S's Cash from Financing Activities growth rate? Cash from Financing Activities CAGR 10Y -10%

Company

Help

Tools

Stocks

Novo Nordisk A/S
CSE:NOVO B

Novo Nordisk A/S
Cash from Financing Activities

Novo Nordisk A/S
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

What is Novo Nordisk A/S's Cash from Financing Activities?

Cash from Financing Activities
-68.9B DKK

What is Novo Nordisk A/S's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 10Y
-10%